These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38953298)

  • 21. MiR-181b-5p modulates chemosensitivity of glioma cells to temozolomide by targeting Bcl-2.
    Zhang X; Yu J; Zhao C; Ren H; Yuan Z; Zhang B; Zhuang J; Wang J; Feng B
    Biomed Pharmacother; 2019 Jan; 109():2192-2202. PubMed ID: 30551476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of ROCK2 through nanocomplex sensitizes the cytotoxic effect of temozolomide in U251 glioma cells.
    Wen X; Huang A; Liu Z; Liu Y; Hu J; Liu J; Shuai X
    PLoS One; 2014; 9(3):e92050. PubMed ID: 24642531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zeolitic Imidazole Framework (ZIF) Nanospheres for Easy Encapsulation and Controlled Release of an Anticancer Drug Doxorubicin under Different External Stimuli: A Way toward Smart Drug Delivery System.
    Adhikari C; Das A; Chakraborty A
    Mol Pharm; 2015 Sep; 12(9):3158-66. PubMed ID: 26196058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma.
    Ling Y; Wei K; Zou F; Zhong S
    Int J Pharm; 2012 Jul; 430(1-2):266-75. PubMed ID: 22486964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential pro-apoptotic effects of synthetic 4-thiazolidinone derivative Les-3288, doxorubicin and temozolomide in human glioma U251 cells.
    Коbylinska LI; Klyuchivska OY; Grytsyna II; Finiuk N; Panchuk RR; Starykovych MO; Lehka L; Lesyk RB; Zіmenkovsky BS; Stoika RS
    Croat Med J; 2017 Apr; 58(2):150-159. PubMed ID: 28409498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer Cell-Targeted Photosensitizer and Therapeutic Protein Co-Delivery Nanoplatform Based on a Metal-Organic Framework for Enhanced Synergistic Photodynamic and Protein Therapy.
    Ding L; Lin X; Lin Z; Wu Y; Liu X; Liu J; Wu M; Zhang X; Zeng Y
    ACS Appl Mater Interfaces; 2020 Aug; 12(33):36906-36916. PubMed ID: 32706242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ATP-triggered mitochondrial cascade reactions for cancer therapy with nanoscale zeolitic imidazole framework-90.
    Pan W; Cui B; Wang K; Shi M; Lu F; Li N; Tang B
    Theranostics; 2021; 11(16):7869-7878. PubMed ID: 34335969
    [No Abstract]   [Full Text] [Related]  

  • 28. Zeolitic Imidazolate framework-8 as efficient pH-sensitive drug delivery vehicle.
    Sun CY; Qin C; Wang XL; Yang GS; Shao KZ; Lan YQ; Su ZM; Huang P; Wang CG; Wang EB
    Dalton Trans; 2012 Jun; 41(23):6906-9. PubMed ID: 22580798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hispidulin Enhances Temozolomide (TMZ)-Induced Cytotoxicity against Malignant Glioma Cells
    Chen Z; Zhu G; Sheng C; Lei J; Song S; Zhu J
    Comput Intell Neurosci; 2022; 2022():5266770. PubMed ID: 35800695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanoscale Melittin@Zeolitic Imidazolate Frameworks for Enhanced Anticancer Activity and Mechanism Analysis.
    Li Y; Xu N; Zhu W; Wang L; Liu B; Zhang J; Xie Z; Liu W
    ACS Appl Mater Interfaces; 2018 Jul; 10(27):22974-22984. PubMed ID: 29920061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A combination of glioma in vivo imaging and in vivo drug delivery by metal-organic framework based composite nanoparticles.
    Pan YB; Wang S; He X; Tang W; Wang J; Shao A; Zhang J
    J Mater Chem B; 2019 Dec; 7(48):7683-7689. PubMed ID: 31778139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual-Targeted Zeolitic Imidazolate Frameworks Drug Delivery System Reversing Cisplatin Resistance to Treat Resistant Ovarian Cancer.
    Xing Y; Jing R; Tang X; Jiang Z
    Int J Nanomedicine; 2024; 19():6603-6618. PubMed ID: 38979533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
    Li C; Feng S; Chen L
    Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folic acid-decorated astrocytes-derived exosomes enhanced the effect of temozolomide against glioma.
    Liu HM; Zhang Y
    Kaohsiung J Med Sci; 2024 May; 40(5):435-444. PubMed ID: 38482902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction Therapy of Retinoic Acid with a Temozolomide-Loaded Gold Nanoparticle-Associated Ultrasound Effect on Glioblastoma Cancer Stem-Like Colonies.
    Fadera S; Chen PY; Liu HL; Lee IC
    ACS Appl Mater Interfaces; 2021 Jul; 13(28):32845-32855. PubMed ID: 34235925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-delivery of carboplatin and doxorubicin using ZIF-8 coated chitosan-poly(N-isopropyl acrylamide) nanoparticles through a dual pH/thermo responsive strategy to breast cancer cells.
    Dashti N; Akbari V; Varshosaz J; Soleimanbeigi M; Rostami M
    Int J Biol Macromol; 2024 Jun; 269(Pt 1):131971. PubMed ID: 38705336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Situ Synthesis of Ultrathin ZIF-8 Film-Coated MSNs for Codelivering Bcl 2 siRNA and Doxorubicin to Enhance Chemotherapeutic Efficacy in Drug-Resistant Cancer Cells.
    Pan QS; Chen TT; Nie CP; Yi JT; Liu C; Hu YL; Chu X
    ACS Appl Mater Interfaces; 2018 Oct; 10(39):33070-33077. PubMed ID: 30203954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FA-PEG decorated MOF nanoparticles as a targeted drug delivery system for controlled release of an autophagy inhibitor.
    Shi Z; Chen X; Zhang L; Ding S; Wang X; Lei Q; Fang W
    Biomater Sci; 2018 Sep; 6(10):2582-2590. PubMed ID: 30151542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Honokiol enhances temozolomide-induced apoptotic insults to malignant glioma cells via an intrinsic mitochondrion-dependent pathway.
    Chio CC; Tai YT; Mohanraj M; Liu SH; Yang ST; Chen RM
    Phytomedicine; 2018 Oct; 49():41-51. PubMed ID: 30217261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined Delivery of Temozolomide and siPLK1 Using Targeted Nanoparticles to Enhance Temozolomide Sensitivity in Glioma.
    Shi H; Sun S; Xu H; Zhao Z; Han Z; Jia J; Wu D; Lu J; Liu H; Yu R
    Int J Nanomedicine; 2020; 15():3347-3362. PubMed ID: 32494134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.